Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

Publication | Closed Access

DOI

Citations

References

2015

Year

Uwe Platzbecker, Raymond Wong, Amit Verma, Camille N. Abboud, Sérgio Araujo, Tzeon-Jye Chiou, John Feigert, Su‐Peng Yeh, Katharina S. Götze, Norbert Claude Gorin,

The Lancet Haematology

Eltrombopag Versus PlaceboThrombosisHematological MalignancyVenous ThrombosisOncologyHealth SciencesHematologyClinical TrialsAcute Myeloid LeukaemiaAnticoagulantPharmacotherapyPlatelet AntagonistMedicineRadiation OncologyAdvanced Myelodysplastic Syndromes